Showing results (761-770 of 782) with videos related to
Sort By:
Pageof 79
Blood|June 10, 2018
Identification of novel mutational drivers reveals oncogene dependencies in multiple myelomaBrian A Walker, Konstantinos Mavrommatis, Christopher P Wardell, et al.Blood|September 26, 2018
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myelomaAurore Perrot, Valerie Lauwers-Cances, Jill Corre, et al.British Journal of Haematology|March 16, 2021
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerationsLaura Rosiñol, Meral Beksac, Elena Zamagni, et al.Blood|November 19, 2017
Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myelomaThierry Facon, Meletios A Dimopoulos, Angela Dispenzieri, et al.Nature Communications|June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplantTarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.The New England Journal of Medicine|May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myelomaPhilip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.The Lancet. Haematology|August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialSarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.Cancer Research|March 22, 2018
Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple MyelomaXiaomu Wei, M Nieves Calvo-Vidal, Siwei Chen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaHervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2021
Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug RegistrationKenneth C Anderson, Daniel Auclair, Stacey J Adam, et al.Pageof 79